DƯỢC LÍ Goodman & Gilman's The Pharmacological Basis of Therapeutics 12th, 2010

Feldman SA, Fauvel N. Onset of neuromuscular block. In,
Applied Neuromuscular Pharmacology. (Pollard BJ, ed.)
Oxford University Press, Oxford, England, 1994, pp. 69–84.
Flynn TC. Update on botulinum toxin. Semin Cutan Med Surg,
2006, 25:115–121.
Fogdall RP, Miller RD. Neuromuscular effects of enflurane,
alone and combined with D-tubocurarine, pancuronium, and
succinylcholine, in man. Anesthesiology, 1975, 42:173–178.
Frishman WH. Smoking cessation pharmacotherapy. Ther Adv
Cardiovasc Dis, 2009, 3:287–308.
Fruen BR, Mickelson JR, Louis CF. Dantrolene inhibition of sarcoplasmic
reticulum Ca 2+ release by direct and specific action
at skeletal muscle ryanodine receptors. J Biol Chem, 1997,
272:26965–26971.
Fukusaki M, Miyako M, Hara T, et al. Effects of controlled
hypotension with sevoflurane anesthesia on hepatic function of
surgical patients. Eur J Anaesthesiol, 1999, 16:111–116.
Gronert GA, Pessah IN, Muldoon SM, et al. Malignant
Hyperthermia. In, Miller’s Anesthesia, 6th ed. (Miller RD, ed.)
Churchill-Livingstone, Philadelphia, 2005, pp. 1169–1190.
Gurney AM, Rang HP. The channel-blocking action of methonium
compounds on rat submandibular ganglion cells. Br J
Pharmacol, 1984, 82:623–642.
Hunter JM. Muscle relaxants in renal disease. Acta Anaesthesiol
Scand Suppl, 1994, 102:2–5.
Karlin A. Emerging structures of nicotinic acetylcholine receptors.
Nature Rev Neurosci, 2002, 3:102–114.
Katz B, Miledi R. A re-examination of curare action at the motor
end plate. Proc R Soc Lond [Biol], 1978, 203:119–133.
Kita M, Goodkin DE. Drugs used to treat spasticity. Drugs, 2000,
59:487–495.
Kuryatov A, Luo J, Cooper J, et al. Nicotine acts as a pharmacological
chaperone to up-regulate human a4b2 acetylcholine
receptors. Mol Pharm, 2005, 68: 1839–1851.
Lehmann-Horn F, Jurkat-Rott K. Voltage-gated ion channels and
hereditary disease. Physiol Rev, 1999, 79:1317–1372.
Lester HA, Xiao C, Srinivasan R, et al. Nicotine is a selective
pharmacological chaperone of acetylcholine receptor number
and stoichiometry. Implications for drug discovery. AAPS J,
2009, 11:167–177.
MacDermott AB, Role LW, Siegelbaum SA. Presynaptic ionotropic
receptors and the control of transmitter release. Annu
Rev Neurosci, 1999, 22:443–485.
Mihalak KB, Carroll FI, Luetje CW. Varenicline is a partial agonist
at α4β2 and a full agonist at α7 neuronal nicotinic receptors.
Mol Pharmacol, 2006, 70: 801–805.
Naguib M, Brull SJ. Update on neuromuscular pharmacology.
Curr Opin Anaesthesiol, 2009, 22:483–490.
Naguib M, Lien CA. Pharmacology of Muscle Relaxants
and Their Antagonists. In, Miller’s Anesthesia, 6th ed.
(Miller RD, ed.) Churchill-Livingstone, Philadelphia, 2005,
pp. 481–572.
Numa S, Noda M, Takahashi H, et al. Molecular structure of the
nicotinic acetylcholine receptor. Cold Spring Harbor Symp
Quant Biol, 1983, 48:57–69.
Pantuck EJ. Plasma cholinesterase: gene and variations. Anesth
Analg, 1993, 77:380–386.
Pollard BJ. Interactions involving relaxants. In, Applied
Neuromuscular Pharmacology. (Pollard BJ, ed.) Oxford
University Press, Oxford, England, 1994, pp. 202–248.
Primo-Parmo SL, Bartels CF, Wiersema B, et al. Characterization
of 12 silent alleles of the human butyrylcholinesterase (BCHE)
gene. Am J Hum Genet, 1996, 58:52–64.
Prud’homme M, Houdeau E, Serghini R, et al. Small intensely
fluorescent cells of the rat paracervical ganglion. Brain Res,
1999, 821:141–149.
Rollema H, Coe JW, Chambers LK, et al. Rationale, pharmacology
and clinical efficacy of partial agonists of α4β2 nACh
receptors for smoking cessation. Trends Pharmacol Sci, 2007,
28:316–325.
Rosenberg H, Davis M, James D, et al. Malignant Hyperthermia.
Orphanet J Rare Dis, 2007, 2:21–35
Sakmann B. Elementary steps in synaptic transmission revealed by
currents through single ion channels. Science, 1992, 256:503–512.
Savarese JJ. Upcoming Improvements in Relaxation &
Reversal. In, Clinical Anesthesiology, 4th ed. (Morgan GE Jr.,
Mikhail MS, Murray MJ, eds.) McGraw-Hill, New York,
2006, pp. 216–217.
Sine SM, Claudio T. γ- and δ-subunits regulate the affinity and
cooperativity of ligand binding to the acetylcholine receptor.
J Biol Chem, 1991, 266:19369–19377.
Sine SM, Gao F, Lee WY, et al. Recent structural and mechanistic
insights into endplate acetylcholine receptors. Ann NY Acad
Sci, 2008, 1132:53-60.
Slavikova J, Kuncova J, Reischig J, et al. Catecholaminergic neurons
in the rat intrinsic cardiac nervous system. Neurochem
Res, 2003, 28:593–598.
Smith S, Brown H, Toman J, Goodman L. The lack of cerebral
effects of D-tubocurarine. Anesthesiology, 1947, 8:1–14.
Stensrud PE. Anesthesia at Remote Locations. In, Miller’s
Anesthesia, 6th ed. (Miller RD, ed.) Churchill-Livingstone,
Philadelphia, 2005, pp. 2637–2664.
Strawn JR, Keck PE Jr, Caroff SN. Neuroleptic Malignant
Syndrome. Am J Psychiatry, 2007, 164:870–876.
Taylor P, Brown RD, Johnson DA. The linkage between ligand
occupation and response of the nicotinic acetylcholine receptor.
In, Current Topics in Membranes and Transport, vol. 18.
(Kleinzeller A, Martin BR, eds.) Academic Press, New York,
1983, pp. 407–444.
Taylor P, Talley TT, Radic Z, et al. Structure-guided drug design:
Conferring selectivity among neuronal nicotinic receptor and
acetylcholine-binding protein subtypes. Biochem Pharmacol,
2007, 74:1164–1171.
Unwin N. Nicotinic acetylcholine receptor at 9 Å resolution.
J Mol Biol, 1993, 229:1101–1124.
Unwin N. Refined structure of the nicotinic acetylcholine receptor
at 4 Å resolution. J Mol Biol, 2005, 346:967–989.
Van der Kloot W, Molgo J. Quantal acetylcholine release at the vertebrate
neuromuscular junction. Physiol Rev, 1994, 74:899–991.
van der Spek AF, Reynolds PI, Fang WB, et al. Changes in
resistance to mouth opening induced by depolarizing and nondepolarizing
neuromuscular relaxants. Br J Anaesth, 1990,
64:21–27.
Viby-Mogensen J. Neuromuscular Monitoring. In, Miller’s
Anesthesia, 6th ed. (Miller RD, ed.) Churchill-Livingstone,
Philadelphia, 2005, pp. 1551–1569.
Vita GM, Olckers A, Jedlicka AE, et al. Masseter muscle rigidity
associated with glycine 1306-to-alanine mutation in the
adult muscle sodium channel α-subunit gene. Anesthesiology,
1995, 82:1097–1103.
275
CHAPTER 11
AGENTS ACTING AT THE NEUROMUSCULAR JUNCTION AND AUTONOMIC GANGLIA